1. Pathology Sciences, AstraZeneca R&D, Macclesfield, United Kingdom;
2. School of Biosciences, Cardiff University, Cardiff, United Kingdom;
3. Department of Medicine, UCSF School of Medicine, San Francisco, California;
4. Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and
5. Division of Nephrology and Hyperension, Eastern Virginia Medical School, Norfolk, Virginia